from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2J0TdkX on May 30, 2018 at 03:49PM
The U.S. Food and Drug Administration is shining the spotlight on biosimilars and other interchangeable products in a new five-part video series published on YouTube.
Featuring FDA Commissioner Scott Gottlieb and Director of OND Therapeutics Biologics and Biosimilars Staff Leah Christl, the first video focuses on the potential biosimilars have to boost treatment options, create more access to life-saving treatments and even trim health costs.
“More and more drugs we see coming onto the market are biological products, and so a lot of the important treatments for cancers, a lot of important treatment for rare diseases or different disorders, are biological products,” Gottlieb says.
To read more on Specialty Pharmacy Times, click here.